Hyo‐Gyoung Kang

769 citations
34 papers · 561 indexed · h-index 14
Topics
Lung Cancer Treatments and Mutations (14 papers)Lung Cancer Research Studies (11 papers)RNA modifications and cancer (10 papers)
Partner nations
South KoreaSudanEthiopia

In The Last Decade

Hyo‐Gyoung Kang

33 papers receiving 558 citations

Peers

Hyo‐Gyoung Kang
Comparison fields: 5 of 64
  • Molecular Biology 342
  • Oncology 182
  • Cancer Research 150
  • Pulmonary and Respiratory Medicine 135
  • Physiology 66
Replace Sandy Chevrier with:
Sandy Chevrier France
Wenshan Zhao China
Eric H. Bent United States
Barbara Lipert New Zealand
Florian Bellutti Austria
Eva Schruf Germany
Liangsheng Fan China
Claudia Corrò Switzerland
Sheeba Jacob India
Bowen Yuan China
Hyo‐Gyoung Kang relative to Sandy Chevrier France Sandy Chevrier's profile →
Citations per field
00.5×8.3×
Sandy Chevrier · 1×
Citations per year

Countries citing papers authored by Hyo‐Gyoung Kang

Since Specialization
Citations

This map shows the geographic impact of Hyo‐Gyoung Kang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hyo‐Gyoung Kang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hyo‐Gyoung Kang more than expected).

Fields of papers citing papers by Hyo‐Gyoung Kang

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Hyo‐Gyoung Kang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hyo‐Gyoung Kang. The network helps show where Hyo‐Gyoung Kang may publish in the future.

Co-authorship network of co-authors of Hyo‐Gyoung Kang

This figure shows the co-authorship network connecting the top 25 collaborators of Hyo‐Gyoung Kang. A scholar is included among the top collaborators of Hyo‐Gyoung Kang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Hyo‐Gyoung Kang. Hyo‐Gyoung Kang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
#WorkIndexed citations
1 0
2 2
3 2
4 3
5 5
6 2
7 6
8 1
9 3
10 36
11 45
12 1
13 35
14 27
15 19
16 52
17 53
18 25
19 25
20 28

About Hyo‐Gyoung Kang

Hyo‐Gyoung Kang is a scholar working on Cancer Research, Oncology and Pulmonary and Respiratory Medicine, having authored 34 papers that have together received 561 indexed citations. Recurring topics across this work include Lung Cancer Treatments and Mutations (14 papers), Lung Cancer Research Studies (11 papers) and RNA modifications and cancer (10 papers). The work is most often cited by research in Cancer Research (150 citations), Oncology (182 citations) and Aging (10 citations). Hyo‐Gyoung Kang has collaborated with scholars based in South Korea, Sudan and Ethiopia. Frequent co-authors include Jae Yong Park, Chang Ho Kim, Won Kee Lee, Jin Eun Choi, Tae Hoon Jung, Sin Kam, Seung Ick, Shin Yup Lee, Eung Bae Lee and Yi Young Choi. Their work appears in journals such as Scientific Reports, Gene and Annals of Surgical Oncology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026